Average Co-Inventor Count = 6.62
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharmaceuticals Corporation (12 from 70 patents)
2. Bayer Corporation (5 from 1,008 patents)
3. Bayer Healthcare LLC (5 from 780 patents)
4. Other (1 from 832,680 patents)
5. Bayer Intellectual Property Gmbh (1 from 721 patents)
24 patents:
1. 8796250 - Diaryl ureas for diseases mediated by PDGFR
2. 8501755 - Tetrahydropyridothienopyrimidine compounds and methods of use thereof
3. 8207166 - Substituted pyrazolyl urea derivatives useful in the treatment of cancer
4. 7838524 - Substituted pyrazolyl urea derivatives useful in the treatment of cancer
5. 7803956 - Benzofuran derivatives useful for treating hyper-proliferative disorders
6. 7659412 - Benzofuran derivatives useful for treating hyper-proliferative disorders
7. 7585888 - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
8. 7429584 - Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders
9. 7420066 - Benzofuran derivatives useful for treating hyper-proliferative disorders
10. 7384947 - Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11. 7351735 - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12. 7238701 - Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
13. 7144885 - Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
14. 6919371 - 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
15. 6903218 - Sulfonamide substituted chroman derivatives